Daniele Canzio, PhD, of the Department of Neurology and Balyn Zaro, PhD, of the Department of Pharmaceutical Chemistry have ...
Huntington’s disease is a rare inherited neurological disorder that progressively affects movement, cognition and mental ...
Neurological disorders affect the function of the nervous system. Common pediatric neurological disorders include ADHD, autism spectrum disorder, epilepsy, and cerebral palsy. Neurological disorders ...
Patients with CaV2.1 channelopathies face severe and often debilitating symptoms, such as seizures, migraines, tremors, and ...
A neurologic disorder is any condition that affects the brain and nerves throughout the body. Common neurologic conditions in children include epilepsy, cerebral palsy, attention deficit hyperactivity ...
News-Medical.Net on MSN
Research highlights global neurosurgical workforce shortages and systemic barriers
Neurological disorders contribute to nearly nine million deaths globally each year, and an estimated 22.6 million new cases ...
Genetic testing can help doctors diagnose some neurological disorders, such as Huntington’s disease. It can also provide insights into a person’s risk of future health conditions. Genetic testing ...
Most people experience headaches regularly and dismiss them as stress, dehydration, or simple tension. However, what feels like an ordinary headache could actually represent the early warning signs of ...
Neurological conditions such as Parkinson’s disease and poststroke syndromes frequently manifest as speech disorders, with dysarthria being among the most prominent. These disorders, which affect ...
At the 2nd International Glaucoma Symposium in Mainz, Germany, on 31 January 2026, optical coherence tomography (OCT) and its role in glaucoma and neuro-ophthalmic disease took centre stage in a ...
Imagine suddenly losing the ability to move a limb, walk or speak. You would probably recognise this as a medical emergency and get to hospital. Now imagine the doctors at the hospital run some tests ...
Marvel Biosciences’ lead therapeutic candidate, MB-204 receives Japanese patent: Calgary, Alberta Thursday, February 5, 2026, 10:00 Hrs [IST] Marvel Biosciences Corporation and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results